RETRACTED ARTICLE: TRIM29 facilitates the epithelial-to-mesenchymal transition and the progression of colorectal cancer via the activation of the Wnt/β-catenin signaling pathway
Open Access
- 27 February 2019
- journal article
- retracted article
- Published by Springer Nature in Journal of Experimental & Clinical Cancer Research
- Vol. 38 (1) , 1-15
Abstract
Background: Tripartite Motif 29 (TRIM29) has been newly identified as being implicated in cancer progression. However, the biological role and molecular mechanism of TRIM29 in the invasion and metastasis of colorectal cancer (CRC) remain to be determined. Methods: The expression levels of TRIM29 and β-catenin in CRC patient specimens were detected by immunohistochemistry. Recombinant lentivirus vectors containing the TRIM29 gene and its small hairpin interfering RNAs were constructed and transduced into CRC cells. Wound-healing and Transwell assays were performed to evaluate the migration and invasion abilities of CRC cells in vitro. Hepatic metastasis models in nude mice were established to validate the function of TRIM29 in vivo. Moreover, the expressions of epithelial-to-mesenchymal transition (EMT)-associated proteins were detected by qRT-PCR and Western blotting in CRC cells. Finally, Western blotting, qRT-PCR, luciferase reporter assays, and immunofluorescence assays were used to explore the molecular mechanisms of TRIM29 in CRC progression. Results: Increased TRIM29 expression positively correlated with lymph node metastasis and β-catenin expression in patient CRC tissues. Overexpression of TRIM29 promoted invasion and metastasis of CRC cells in vitro and in vivo by regulating EMT, whereas the knockdown of TRIM29 had the opposite effect. Further mechanistic studies suggest that TRIM29 can activate the Wnt/β-catenin signaling pathway via up-regulating CD44 expression in colorectal cancer. Conclusions: TRIM29 induces EMT through activating the Wnt/β-catenin signaling pathway via up-regulating CD44 expression, thus promoting invasion and metastasis of CRC.Keywords
Funding Information
- Shanghai Committee of Science and Technology Foundation (No.16411950402)
- Shanghai Health and Family Planning Committee (No.201640112)
This publication has 44 references indexed in Scilit:
- CD44 targets Wnt/β-catenin pathway to mediate the proliferation of K562 cellsCancer Cell International, 2013
- Ataxia-Telangiectasia Group D Complementing Gene (ATDC) Promotes Lung Cancer Cell Proliferation by Activating NF-κB PathwayPLOS ONE, 2013
- Dysregulation of Wnt/β-Catenin Signaling in Gastrointestinal CancersGastroenterology, 2012
- E‐Cadherin/β‐Catenin Complex and the Epithelial BarrierBioMed Research International, 2011
- The ATDC (TRIM29) Protein Binds p53 and Antagonizes p53-Mediated FunctionsMolecular and Cellular Biology, 2010
- GSK3: a multifaceted kinase in Wnt signalingTrends in Biochemical Sciences, 2010
- Epithelial-Mesenchymal Transitions in Development and DiseaseCell, 2009
- The basics of epithelial-mesenchymal transitionJournal of Clinical Investigation, 2009
- Oncogenic Function of ATDC in Pancreatic Cancer through Wnt Pathway Activation and β-Catenin StabilizationCancer Cell, 2009
- Complex networks orchestrate epithelial–mesenchymal transitionsNature Reviews Molecular Cell Biology, 2006